- Home
- NTHI vs AKA Comparison
NTHI vs AKA Comparison
Compare NTHI & AKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTHI | AKA |
|---|---|---|
| Founded | 2008 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.0M | 105.4M |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NTHI | AKA |
|---|---|---|
| Price | $2.77 | $10.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $17.00 | ★ $19.75 |
| AVG Volume (30 Days) | ★ 139.3K | 890.0 |
| Earning Date | 11-13-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $39,990.00 | ★ $600,208,000.00 |
| Revenue This Year | N/A | $4.92 |
| Revenue Next Year | N/A | $5.05 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 4.44 |
| 52 Week Low | $2.50 | $8.42 |
| 52 Week High | $12.00 | $15.38 |
Technical Indicators
Market Signals| Indicator | NTHI | AKA |
|---|---|---|
| Relative Strength Index (RSI) | 43.05 | 42.39 |
| Support Level | $2.50 | $10.23 |
| Resistance Level | $3.70 | $11.43 |
| Average True Range (ATR) | 0.25 | 0.35 |
| MACD | 0.03 | -0.07 |
| Stochastic Oscillator | 34.98 | 33.82 |
Price Performance
Historical ComparisonAbout NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
About AKA a.k.a. Brands Holding Corp.
a.k.a. Brands Holding Corp is a portfolio of fashion brands, including Princess Polly, Culture Kings, Petal & Pup, and mnml. Through these brands, the company reaches next-generation consumers who seek fashion inspiration on social media and mainly shop online. The portfolio consists of two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company generates the majority of its revenue from the United States.